18 research outputs found
Double Photosystems-Based ‘Z-Scheme’ Photoelectrochemical Sensing Mode for Ultrasensitive Detection of Disease Biomarker Accompanying Three-Dimensional DNA Walker
A new
double photosystems-based ‘Z-scheme’ photoelectrochemical
(PEC) sensing platform is designed for ultrasensitive detection of
prostate-specific antigen (PSA) by coupling with a three-dimensional
(3D) DNA walker. Two photosystems consist of CdS quantum dots (photosystem
I; PS I) and BiVO<sub>4</sub> photoactive materials (photosystem II;
PS II), whereas gold nanoparticles (AuNPs) photodeposited on high-active
{010} facets of BiVO<sub>4</sub> are used as the electron mediators
to promote electron transfer from conduction band of PS II to valence
band of PS I. 3D DNA walker-based amplification strategy is carried
out between hairpin DNA1 conjugated onto the AuNP, hairpin DNA2 labeled
with CdS quantum dot (QD-H2), and DNA walker complementary with the
PSA aptamer modified to a magnetic bead (Apt-MB). Upon addition of
target, DNA walker strand is displaced from DNA walker/Apt-MB to open
hairpin DNA1 on AuNP@BiVO<sub>4</sub>. In the presence of QD-H2, DNA
walker induces the hybridization of DNA1 with DNA2 on the gold nanoparticles
step by step, thereby resulting in the assembly of CdS QDs on the
AuNP@BiVO<sub>4</sub> to form Z-scheme double photosystems with strong
photocurrent. Under optimum conditions, the Z-scheme PEC sensing system
exhibits good photocurrent responses toward target PSA within the
working range of 0.01–50 ng mL<sup>–1</sup> at a low
detection limit of 1.5 pg mL<sup>–1</sup>. Good reproducibility
and accuracy are acquired for analysis of target PSA and human serum
specimens relative to the commercial PSA ELISA kit. Importantly, our
strategy provides a new horizon for photoelectrochemical in vitro
diagnostics
Additional file 3: Figure S2. of Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats
The non-fasting blood glucose after the combination treatment of HFD and STZ for 6 weeks. (n = 6 per group; **p < 0.01). HFD high-fat diet, STZ, streptozotocin. (TIF 135 kb
Light-Enhanced Hypoxia-Response of Conjugated Polymer Nanocarrier for Successive Synergistic Photodynamic and Chemo-Therapy
The
tumor hypoxic environment as well as photodynamic therapy
(PDT)-induced hypoxia could severely limit the therapeutic efficacy
of traditional PDT. Fortunately, the smart integration of hypoxia-responsive
drug delivery system with PDT might be a promising strategy to enhance
the PDT efficiency that is hindered by the hypoxic environment.
Herein, a novel azobenzene (AZO) containing conjugated polymers (CPs)-based
nanocarriers (CPs-CPT-Ce6 NPs) was constructed for the combination
of PDT with chemotherapy, as well as to enhance the hypoxia-responsive
drug release by light. The conjugated polymer chains, used as a matrix
to prepare the CPs-CPT-Ce6 NPs, were beneficial for loading hydrophobic
photosensitizers and chemotherapy drugs, to improve their cellular
uptake. Moreover, the AZO group (−NN−) in CPs,
which can be reduced and cleaved by azoreductase (a typical biomarker
of hypoxia) under the hypoxic environment of tumor cells, acts as
the hypoxia-responsive linker component. Upon laser irradiation, the
CPs-CPT-Ce6 NPs could produce ROS for PDT and then facilitate the
enhancement of tumor hypoxic condition, which could further promote
the dissociation of CPs via reductive cleavage of AZO bridges to subsequently
release cargos (chemotherapeutic drug, CPT) and then significantly
enhance the killing effects to tumor cells that were resistant to
PDT. Both in vitro and in vivo studies confirmed the improvement of
synergistic therapeutic effects of our CPs-CPT-Ce6 NPs. This cascade
responsive approach provides an excellent complementary mode for PDT
and could open new insights for constructing programmable and controllable
responsive systems in biomedical applications
Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy
Photodynamic
therapy (PDT), using a combination of chemical photosensitizers (PS)
and light, has been successfully applied as a noninvasive therapeutic
procedure to treat tumors by inducing apoptosis or necrosis of cancer
cells. However, most current clinically used PS have suffered from
the instability in physiological conditions which lead to low photodynamic
therapy efficacy. Herein, a highly biocompatible polyÂ(dopamine) (PDA)
nanoparticle conjugated with Chlorin e6 (referenced as the PDA-Ce6
nanosphere) was designed as a nanotherapeutic agent to achieve simultaneous
photodynamic/photothermal therapy (PDT/PTT). Compared to the free
Ce6, the PDA-Ce6 nanosphere exhibited significantly higher PDT efficacy
against tumor cells, because of the enhanced cellular uptake and subsequently
greater reactive oxygen species (ROS) production upon laser irradiation
at 670 nm. Meanwhile, the PDA-Ce6 nanosphere could be also used as
a photoabsorbing agent for PTT, because of the excellent photothermal
conversion ability of PDA nanoparticle under laser irradiation at
808 nm. Moreover, our prepared nanosphere had extremely low dark toxicity,
while excellent phototoxicity under the combination laser irradiation
of 670 and 808 nm, both <i>in vitro</i> and <i>in vivo</i>, compared to any single laser irradiation alone. Therefore, our
prepared PDA-Ce6 nanosphere could be applied as a very promising dual-modal
phototherapeutic agent for enhanced cancer therapy in future clinical
applications
Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics
Hepatitis
B virus (HBV) is the main cause of hepatocellular carcinoma
(HCC) in southeast Asia where HBV genotype B and genotype C are the
most prevalent. Viral genotypes have been reported to significantly
affect the clinical outcomes of HCC. However, the underlying molecular
differences among different genotypes of HBV virus infected HCC have
not been revealed. Here, we applied isobaric tags for relative and
absolute quantitation (iTRAQ) technology integrated with liquid chromatography–tandem
mass spectrometry (LC–MS/MS) analysis to identify the proteome
differences between the HBV genotypes B- and C-induced HCC. In brief,
a total of 83 proteins in the surrounding noncancerous tissues and
136 proteins in the cancerous tissues between HBV genotype-B- and
genotype-C-induced HCC were identified, respectively. This information
revealed that there might be different molecular mechanisms of the
tumorigenesis and development of HBV genotypes B- and C-induced HCC.
Furthermore, our results indicate that the two proteins ARFIP2 and
ANXA1 might be potential biomarkers for distinguishing the HBV genotypes
B- and C-induced HCC. Thus, the quantitative proteomic analysis revealed
molecular differences between the HBV genotypes B- and C-induced HCC,
and might provide fundamental information for further deep study
Gadolinium-doped hollow CeO<sub>2</sub>-ZrO<sub>2</sub> nanoplatform as multifunctional MRI/CT dual-modal imaging agent and drug delivery vehicle
<p>Developing multifunctional nanoparticle-based theranostic platform for cancer diagnosis and treatment is highly desirable, however, most of the present theranostic platforms are fabricated via complicated structure/composition design and time-consuming synthesis procedures. Herein, the multifunctional Gd/CeO<sub>2</sub>-ZrO<sub>2</sub>/DOX-PEG nanoplatform with single nano-structure was fabricated through a facile route, which possessed MR/CT dual-model imaging and chemotherapy ability. The nanoplatform not only exhibited well-defined shapes, tunable compositions and narrow size distributions, but also presented a well anti-cancer effect and MR/CT imaging ability. Therefore, the Gd/CeO<sub>2</sub>-ZrO<sub>2</sub>/DOX-PEG nanoplatform could be applied for chemotherapy as well as dual-model MR/CT imaging.</p
Additional file 3 of Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma
Additional file 3: Supplementary Fig. S1. The expression and interaction of 42 PRGs. (A) PPI network showing the interactions of the PRGs (interaction score = 0.9). (B) The correlation network of the PRGs (red line: positive correlation; blue line: negative correlation. The depth of the colors reflects the strength of the relevance)
Additional file 2 of Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma
Additional file 2
Additional file 5 of Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma
Additional file 5: Supplementary Fig. S3. The correlation of gene expression with each type of immune cell infiltration
Additional file 4 of Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma
Additional file 4: Supplementary Fig. S2. The Volcano plots of DEGs between HCC tissues and adjacent tissues